Reach Us +44-1235-425476
Medical Complications in Lung Transplant Recipients with Pulmonary Fibrosis | OMICS International | Abstract
ISSN: 2161-105X

Journal of Pulmonary & Respiratory Medicine
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Review Article

Medical Complications in Lung Transplant Recipients with Pulmonary Fibrosis

Kamyar Afshar*, Ngozi Orjioke, and Timothy Whelan

Division of Pulmonary and Critical Care, University of Southern California, Keck School of Medicine, USA

*Corresponding Author:
Kamyar Afshar
Assistant Professor of Clinical Medicine
University of Southern California
Keck School of Medicine
Division of Pulmonary and Critical Care
2020 Zonal Ave, IRD 723, Los Angeles, CA 90033
Tel: 323-226-7923
Fax: 323-226-2873
E-mail: [email protected]

Received date: February 14, 2013; Accepted date: April 02, 2013; Published date: April 05, 2013

Citation: Afshar K, Orjioke N, Whelan T (2013) Medical Complications in Lung Transplant Recipients with Pulmonary Fibrosis. J Pulmon Resp Med 3:145. doi: 10.4172/2161-105X.1000145

Copyright: © 2013 Afshar K, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.


Lung transplantation is a therapeutic option for selected patients with severe interstitial disease who continue to have progressive clinical deterioration. There is a survival advantage for selected patients who undergo transplant, but it primarily improves quality of life after transplantation. Unfortunately, patients with IPF have worse outcomes following lung transplantation due to various factors. This review article will describe several common postoperative complications including an astamotic complications, allograft dysfunction, cardiovascular complications, thromboembolic phenomenon, renal failure, neurologic complications and complications related to the native lung in the single lung transplant recipients.